Psychological impact of anti-VEGF treatments for wet macular degeneration—a review
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1435-702X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Psychological impact of anti-VEGF treatments for wet macular degeneration—a review ; day:4 ; month:6 ; year:2016 ; pages:1-8
Graefe's archive for clinical and experimental ophthalmology ; (4.6.2016), 1-8
- Creator
-
Senra, Hugo
- Contributor
-
Ali, Zaria
Balaskas, Konstantinos
Aslam, Tariq
SpringerLink (Online service)
- DOI
-
10.1007/s00417-016-3384-0
- URN
-
urn:nbn:de:1111-201606057802
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Senra, Hugo
- Ali, Zaria
- Balaskas, Konstantinos
- Aslam, Tariq
- SpringerLink (Online service)
Other Objects (12)
Development of Macular Atrophy in Patients with Wet Age-Related Macular Degeneration Receiving Anti-VEGF Treatment
Anti-VEGF for the management of diabetic macular edema
Vitreomacular interface after anti-VEGF injections in diabetic macular edema
Anti-VEGF : 13 tables
Fibrosis in age-related neovascular macular degeneration in the anti-VEGF era
Visual and anatomic outcomes of sustained single agent anti-VEGF treatment versus double anti-VEGF switching in the treatment of persistent diabetic macular edema
Documentation of adverse events in non-commercial trials of intravitreal injection of anti-VEGF drugs to treat wet age-related macular degeneration (AMD)
Short-term outcomes of switching anti-VEGF agents in eyes with treatment-resistant wet AMD
Subjective health expectations of patients with age-related macular degeneration treated with antiVEGF drugs
The architecture of macular neovascularizations predicts treatment responses to anti-VEGF therapy in neovascular AMD
Book Review: Anti-VEGF Use in Ophthalmology
Future of anti-VEGF: biosimilars and biobetters
Development of Macular Atrophy in Patients with Wet Age-Related Macular Degeneration Receiving Anti-VEGF Treatment
Anti-VEGF for the management of diabetic macular edema
Vitreomacular interface after anti-VEGF injections in diabetic macular edema
Anti-VEGF : 13 tables
Fibrosis in age-related neovascular macular degeneration in the anti-VEGF era
Visual and anatomic outcomes of sustained single agent anti-VEGF treatment versus double anti-VEGF switching in the treatment of persistent diabetic macular edema
Documentation of adverse events in non-commercial trials of intravitreal injection of anti-VEGF drugs to treat wet age-related macular degeneration (AMD)
Short-term outcomes of switching anti-VEGF agents in eyes with treatment-resistant wet AMD
Subjective health expectations of patients with age-related macular degeneration treated with antiVEGF drugs
The architecture of macular neovascularizations predicts treatment responses to anti-VEGF therapy in neovascular AMD
Book Review: Anti-VEGF Use in Ophthalmology
Future of anti-VEGF: biosimilars and biobetters
Development of Macular Atrophy in Patients with Wet Age-Related Macular Degeneration Receiving Anti-VEGF Treatment
Anti-VEGF for the management of diabetic macular edema
Vitreomacular interface after anti-VEGF injections in diabetic macular edema
Anti-VEGF : 13 tables
Fibrosis in age-related neovascular macular degeneration in the anti-VEGF era
Visual and anatomic outcomes of sustained single agent anti-VEGF treatment versus double anti-VEGF switching in the treatment of persistent diabetic macular edema
Documentation of adverse events in non-commercial trials of intravitreal injection of anti-VEGF drugs to treat wet age-related macular degeneration (AMD)
Short-term outcomes of switching anti-VEGF agents in eyes with treatment-resistant wet AMD
Subjective health expectations of patients with age-related macular degeneration treated with antiVEGF drugs
The architecture of macular neovascularizations predicts treatment responses to anti-VEGF therapy in neovascular AMD
Book Review: Anti-VEGF Use in Ophthalmology